Heart & Vascular

Title
The Treatment of Postmenopausal Women with Osteoporosis
Trial Number
204329051612
Number of Participants
10
Principal Investigator

Pauline Camacho

M.D., FACE
Endocrinology
Professor
Eligibility

The study will include ambulatory postmenopausal women, age 60 to 90 years, whose BMD T-score is 2.50 or less at the total hip or femoral neck and at least one moderate (SQ2) or severe (SQ3) vertebral fracture, as assessed by the central vendor at the time of screening, based on DXA scans and lateral spine X-rays.

Purpose

The purpose of this study is to find out more about the study drug AMG 785 when prescribed to women with postmenopausal osteoporosis. This study will see if AMG 785 prevents bone fractures and whether it causes any side effects.

Enrollment

(708) 216-8223

MORE CLINICAL TRIALS

Clinical Trials

For more information call (888) LUHS-888.